Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome

Clinical trial NCT07079696 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07079696
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dup15q Syndrome Autism Spectrum Disorder Therapy All-trans Retinoic Acid

Start date: 2025-09-01
Primary completion: 2027-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.